(D-Ala²)-Leu-Enkephalin-Arg
| Name | (D-Ala²)-Leu-Enkephalin-Arg |
| Category | Enkephalins and Proenkephalins |
| One Letter Code | Y{D-Ala}GFLR |
| Three Letter Code | {Tyr}{D-Ala}{Gly}{Phe}{Leu}{Arg} |
| Molecular Weight | 725.850 |
| Application |
| Kreuter, Jörg, et al. "Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier." Journal of drug targeting 10.4 (2002): 317-325. |
| Schroeder, Ulrike, Petra Sommerfeld, and Bernhard A. Sabel. "Efficacy of oral dalargin-loaded nanoparticle delivery across the blood–brain barrier." Peptides 19.4 (1998): 777-780. |
| Schroeder, Ulrike, et al. "Nanoparticle technology for delivery of drugs across the blood–brain barrier." Journal of pharmaceutical sciences 87.11 (1998): 1305-1307. |
| Chu, Ivan K., et al. "Formation of molecular radical cations of enkephalin derivatives via collision-induced dissociation of electrospray-generated copper (II) complex ions of amines and peptides." Journal of the American Society for Mass Spectrometry 12.10 (2001): 1114-1119. |
| Schröder, Ulrike, and Bernhard A. Sabel. "Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of iv dalargin injections." Brain research 710.1-2 (1996): 121-124. |